KERYDIN
Drug
Sandoz Inc.
Total Payments
$447,972
Transactions
13,647
Doctors
3,197
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $1,995 | 1 | 0 |
| 2021 | $395.01 | 25 | 14 |
| 2020 | $12,755 | 723 | 386 |
| 2019 | $63,776 | 2,919 | 832 |
| 2018 | $55,722 | 3,037 | 968 |
| 2017 | $313,329 | 6,942 | 2,802 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $209,654 | 11,829 | 46.8% |
| Unspecified | $208,232 | 99 | 46.5% |
| Education | $25,740 | 1,716 | 5.7% |
| Consulting Fee | $4,346 | 3 | 1.0% |
Payments by Type
General
$239,740
13,548 transactions
Research
$208,232
99 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| AN OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND PHARMACOKINETICS OF KERYDIN REGISTERED TAVABOROLE TOPICAL SOLUTION 5 IN THE TREATMENT OF ONYCHOMYCOSIS OF THE TOENAIL IN PEDIATRIC SUBJECTS AGES 6 TO 16 YEARS AND 11 MONTHS | PFIZER INC. | $199,925 | 0 |
| AN OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND PHARMACOKINETICS OF KERYDIN REGISTERED TAVABOROLE TOPICAL SOLUTION 5 IN THE TREATMENT OF ONYCHOMYCOSIS OF THE TOENAIL IN PEDIATRIC SUBJECTS AGES 6 TO 16 YEARS AND 11 MONTHS | Pfizer Inc. | $8,308 | 0 |
Top Doctors Receiving Payments for KERYDIN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Albany, NY | $208,232 | 99 |
| , M.D | Dermatology | San Francisco, CA | $3,500 | 1 |
| , DPM | Foot & Ankle Surgery | San Leandro, CA | $1,773 | 104 |
| , DPM | Podiatrist | Bellevue, WA | $1,601 | 68 |
| , DPM | Podiatrist | San Francisco, CA | $1,529 | 51 |
| , DPM | Foot & Ankle Surgery | Plano, TX | $1,436 | 117 |
| , DPM | Foot & Ankle Surgery | Dallas, TX | $1,311 | 93 |
| , DPM | Foot & Ankle Surgery | Lemont, IL | $1,284 | 113 |
| , M.D | Psychiatry | Los Angeles, CA | $1,203 | 82 |
| , MD | General Practice | Garden Grove, CA | $1,186 | 85 |
| James Jacobs | — | Katy, TX | $1,186 | 58 |
| , D.P.M | Foot Surgery | Garden City, NY | $1,171 | 204 |
| , DPM | Foot Surgery | New York, NY | $1,156 | 75 |
| , MD | Dermatology | San Francisco, CA | $1,148 | 34 |
| , DPM | Foot Surgery | New York, NY | $1,121 | 74 |
| , DPM | Foot & Ankle Surgery | Lemont, IL | $1,107 | 106 |
| Edward Fazekas | — | Lakeland, FL | $1,055 | 109 |
| , DPM | Foot & Ankle Surgery | Plano, TX | $1,006 | 69 |
| , DPM | Podiatrist | Lakeland, FL | $1,003 | 104 |
| , D.P.M | Podiatrist | Reisterstown, MD | $1,001 | 42 |
| , DPM | Foot & Ankle Surgery | Mesquite, TX | $967.72 | 81 |
| , DPM | Podiatrist | Carrollton, TX | $895.78 | 43 |
| , D.P.M | Podiatrist | Torrance, CA | $864.79 | 27 |
| , PC | Podiatrist | Evergreen Park, IL | $852.75 | 44 |
| , D.P.M | Foot Surgery | Massapequa, NY | $827.18 | 38 |
Ad
Manufacturing Companies
- Sandoz Inc. $236,240
- PFIZER INC. $203,425
- Pfizer Inc. $8,308
Product Information
- Type Drug
- Total Payments $447,972
- Total Doctors 3,197
- Transactions 13,647
About KERYDIN
KERYDIN is a drug associated with $447,972 in payments to 3,197 healthcare providers, recorded across 13,647 transactions in the CMS Open Payments database. The primary manufacturer is Sandoz Inc..
Payment data is available from 2017 to 2022. In 2022, $1,995 was paid across 1 transactions to 0 doctors.
The most common payment nature for KERYDIN is "Food and Beverage" ($209,654, 46.8% of total).
KERYDIN is associated with 2 research studies, including "AN OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND PHARMACOKINETICS OF KERYDIN REGISTERED TAVABOROLE TOPICAL SOLUTION 5 IN THE TREATMENT OF ONYCHOMYCOSIS OF THE TOENAIL IN PEDIATRIC SUBJECTS AGES 6 TO 16 YEARS AND 11 MONTHS" ($199,925).